DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer

Jiliang Shen1, Senjun Zhou1, Liang Shi1

  • 1Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China.

Oncotarget
|January 28, 2017
PubMed

Insights

Dual-specific phosphatase DUSP1 inhibits gallbladder cancer (GBC) growth and metastasis. Targeting the DUSP1-pERK-MMP2/VEGF pathway may offer new therapeutic strategies for GBC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Dual-specificity phosphatase 1 (DUSP1/MKP1) regulates mitogen-activated protein kinase (MAPK) signaling.
  • DUSP1 plays a role in various cancers, but its function in gallbladder cancer (GBC) is largely uncharacterized.

Purpose of the Study:

  • To investigate the role and mechanism of DUSP1 in gallbladder cancer (GBC) progression.
  • To explore DUSP1 as a potential therapeutic target for GBC.

Main Methods:

  • In vitro studies using GBC cell lines (SGC996 and GBC-SD) to assess proliferation, migration, and invasion.
  • In vivo studies using a mouse xenograft model with SGC996 cells to evaluate tumor growth and metastasis.
  • Analysis of signaling pathways including DUSP1-pERK/MAPK-MMP2 and VEGF expression.

Main Results:

  • DUSP1 significantly inhibited GBC cell proliferation, migration, and invasion in vitro.
  • DUSP1 suppressed GBC tumor growth and metastasis in vivo.
  • Tumor suppression by DUSP1 was mediated through the DUSP1-pERK/MAPK-MMP2 signaling pathway.
  • DUSP1 impaired angiogenesis by suppressing VEGF expression, thereby reducing tumor metastasis.

Conclusions:

  • DUSP1 acts as a tumor suppressor in gallbladder cancer.
  • DUSP1 inhibits GBC growth and metastasis by regulating the DUSP1-pERK-MMP2/VEGF axis.
  • The DUSP1-pERK-MMP2/VEGF signaling pathway represents a potential target for novel GBC therapies and biomarkers.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K